Serotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action

@article{Lucas2007Serotonin4R,
  title={Serotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action},
  author={Guillaume Lucas and Vladimir V. Rymar and Jenny Du and Ouissame Mnie-Filali and Christina F. Bisgaard and Stella Manta and Laura Lamb{\'a}s-se{\~n}as and Ove Wiborg and Nasser Haddjeri and Graciela Piñeyro and Abbas F. Sadikot and Guy Debonnel},
  journal={Neuron},
  year={2007},
  volume={55},
  pages={712-725}
}
View on Elsevier
cell.com
302 Citations
Highly Influential Citations
19
Background Citations
110
Methods Citations
14
Results Citations
12

Figures from this paper

302 Citations

Citation Type

Citation Type

Serotonin 2C receptor antagonists induce fast-onset antidepressant effects
TLDR
The findings reveal that 5-HT2C antagonists are putative fast-onset antidepressants, which act through enhancement of mesocortical dopaminergic signaling.
Serotonin 2C receptor antagonists induce fast-onset antidepressant effects
TLDR
The findings reveal that 5-HT2C antagonists are putative fast-onset antidepressants, which act through enhancement of mesocortical dopaminergic signaling.
Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin4 Receptor Agonists in the Rat
TLDR
In acute conditions, the 5-HT4 agonist prucalopride was able to counteract the inhibitory effect of the selective serotonin reuptake inhibitors (SSRI) fluvoxamine and citalopram on 5- HT neuron impulse flow, in Dorsal Raphé Nucleus cells selected for their high basal discharge.
Pharmacological Blockade of 5-HT7 Receptors as a Putative Fast Acting Antidepressant Strategy
TLDR
Findings indicate that the 5-HT7 receptor antagonists may represent a new class of antidepressants with faster therapeutic action than the commonly prescribed antidepressant fluoxetine.
Role of 5-HT3 Receptors in the Antidepressant Response
TLDR
Major advances in the research of 5-HT3 receptor's roles in neuropsychiatric disorders are reported, with special emphasis on mood and anxiety disorders.
5-HT2B receptors are required for serotonin-selective antidepressant actions
TLDR
The 5-HT2B receptor appears to positively modulate serotonergic activity and to be required for the therapeutic actions of SSRIs, and should be considered as a new tractable target in the combat against depression.
5-HT7 receptor antagonists as a new class of antidepressants.
TLDR
This review summarizes recent data that put emphasis on the putative antidepressant properties of selective 5-HT(7) receptor antagonists and the use of such ligands seems very promising to elaborate novel generations of antidepressants that surpass the efficacy and onset of action limitations of existing antidepressants.
The peptidic antidepressant spadin interacts with prefrontal 5-HT4 and mGluR2 receptors in the control of serotonergic function
TLDR
The results indicate that spadin, as a natural compound, constitutes a very good candidate to explore the “glutamatergic path” of fast-acting AD research, and provide the first evidence of 5-HT depolarization block, showing that the combination of5-HT activators for strategies of AD augmentation should be performed with extreme caution.
Rapid Anxiolytic Effects of a 5-HT4 Receptor Agonist Are Mediated by a Neurogenesis-Independent Mechanism
TLDR
5-HT4 receptor stimulation could represent an innovative and rapid onset therapeutic approach to treat depression with comorbid anxiety and chronic treatment with GR125487 prevented both anxiolytic/antidepressant-like and neurogenic effects of fluoxetine.
Serotonin receptors involved in antidepressant effects.
  • F. Artigas
  • Biology, Psychology
    Pharmacology & therapeutics
  • 2013
...
...

References

SHOWING 1-10 OF 59 REFERENCES
Onset of the Effects of the 5-HT1A Antagonist, WAY-100635, Alone, and in Combination With Paroxetine, on Olfactory Bulbectomy and 8-OH-DPAT–Induced Changes in the Rat
Is there a role for 5-HT1A agonists in the treatment of depression?
Frontocortical 5-HT4 receptors exert positive feedback on serotonergic activity: Viral transfections, subacute and chronic treatments with 5-HT4 agonists
Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1A Receptors
TLDR
Data indicate that such antidepressant treatments, acting on entirely different primary targets, might alleviate depression by enhancing the tonic activation of forebrain postsynaptic 5-HT1Areceptors.
In-vivo modulation of central 5-hydroxytryptamine (5-HT1A) receptor-mediated responses by the cholinergic system.
TLDR
A functional role of muscarinic receptors in the modulation of pre- and post-synaptic 5-HT1A receptors mediated responses is reported, suggesting that atropine could induce an attenuation of somatodendritic 5- HT1A autoreceptors responsiveness.
Novel therapeutic approaches beyond the serotonin receptor
  • R. Duman
  • Biology, Psychology
    Biological Psychiatry
  • 1998
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain
Behavioral Effects of Chronic Fluoxetine in BALB/cJ Mice Do Not Require Adult Hippocampal Neurogenesis or the Serotonin 1A Receptor
TLDR
B/cJ mice show a robust response to chronic SSRI treatment in the FST, which is not mediated by an increase in new neurons in the hippocampus, and does not require the 5-HT1A receptor, suggesting that SSRIs can produce antidepressant-like effects via distinct mechanisms in different mouse strains.
Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: an In Vivo Electrophysiological Study in Rat Brain
TLDR
The results suggest that the time course of the gradual return of presumed 5-HT neuronal firing activity, which was reported to account for the delayed effect of SSRI on5-HT transmission, is congruent with the earlier onset of action of escITALopram vs citalopram in validated animal models of depression and anxiety.
The novel dopamine D4 receptor agonist (PD 168,077 maleate): Doses with different effects on locomotor activity are without effect in classical conditioning
...
...